Quadramet is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Lantheus Medical Imaging, Inc.. The primary component is Samarium Sm-153 Lexidronam Pentasodium.
| Product ID | 11994-016_3f73e214-cad4-4b6d-b1ed-66f1777b57f4 |
| NDC | 11994-016 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Quadramet |
| Generic Name | Samarium Sm 153 Lexidronam |
| Dosage Form | Injection, Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 1997-05-19 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020570 |
| Labeler Name | Lantheus Medical Imaging, Inc. |
| Substance Name | SAMARIUM SM-153 LEXIDRONAM PENTASODIUM |
| Active Ingredient Strength | 50 mCi/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 1997-05-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA020570 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1997-05-19 |
| Ingredient | Strength |
|---|---|
| SAMARIUM SM-153 LEXIDRONAM PENTASODIUM | 50 mCi/mL |
| SPL SET ID: | 61e84808-0999-4923-910c-2a480d5f971a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() QUADRAMET 78374967 2897509 Live/Registered |
LANTHEUS MEDICAL IMAGING, INC. 2004-02-26 |
![]() QUADRAMET 74653588 2046461 Dead/Cancelled |
CYTOGEN Corporation 1995-03-30 |